±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1456  |  »Ø¸´: 10
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßludedai½«ÔùËÍÄú 100 ¸ö½ð±Ò

ludedai

Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)

[ÇóÖú] Ͷ¸åÇóÖú ÒÑÓÐ5È˲ÎÓë

ÓÐÈËͶ¹ýJournal of Materials ScienceÕâ¸öÆÚ¿¯Âð£¬ÎÒÃÇÕýÎÄÖÐÒѾ­¼ÓÁËÖÂлµÈ£¬±à¼­Ò»Ö±·¢µÄÕâ¸öÓʼþ£¬ÓÐÖªµÀµÄÄܰïÎÒ½â´ðÒ»ÏÂÎÊÌâ³öÔÚÄÄÀÍò·Ö¸Ðл£¡
The following statements should be present before the reference section.
Acknowledgments: A list of people who contributed to the work in the manuscript but who are not named in the author list and a list of funding sources that supported the research presented. The Acknowledgments should appear as a separate section before the reference list. The names of funding organizations should be written in full.
Author contributions: An optional statement of each author¡¯s input into the manuscript, such as conception, experimental design, carrying out measurements and manuscript composition. CASRAI offer a taxonomy for identifying and describing contributor roles (CRediT).
Conflicts of interest or competing interests: A statement that declares all relationships or interests of the manuscript¡¯s authors that could potentially influence or bias the submitted work. If no conflicts of interest exist, the authors must include a statement stating this. Details on potential conflicts of interest are included under Publishing Ethics. Manuscripts that do not include a conflict of interest statement will be returned to the authors for amendment before any editorial consideration.
Data and code availability: A brief description what data or code is available to readers and how it can be accessed, for example, a DOI to an electronic repository.
Supplementary information: A brief description of any additional material omitted from the main body in the interest of presenting a clearer and more readable manuscript.
Ethical approval: A statement that approval was granted to carry out experiments involving human tissue by an institutional review board or equivalent ethics committee.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
»ØÌûÖ§³Ö ( ÏÔʾ֧³Ö¶È×î¸ßµÄǰ 50 Ãû )

¿É´ïѼ²»¿Ê

½û³æ (СÓÐÃûÆø)

±¾ÌûÄÚÈݱ»ÆÁ±Î

8Â¥2023-06-14 09:53:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÆÕͨ»ØÌû

newind

½ð³æ (ÖªÃû×÷¼Ò)

°´ÒªÇó¸Ä£¿ÐèÒªÌṩ×÷Õß·Ö¹¤£¿

·¢×ÔСľ³æAndroid¿Í»§¶Ë
it'smylife£¬nowornever
2Â¥2023-06-08 12:00:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ludedai

Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)

ÒýÓûØÌû:
2Â¥: Originally posted by newind at 2023-06-08 12:00:22
°´ÒªÇó¸Ä£¿ÐèÒªÌṩ×÷Õß·Ö¹¤£¿

×÷Õß·Ö¹¤ÔÚ×÷Õß¹±Ï×ÀïдÁË
3Â¥2023-06-08 12:03:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

newind

½ð³æ (ÖªÃû×÷¼Ò)

ÒýÓûØÌû:
3Â¥: Originally posted by ludedai at 2023-06-08 12:03:20
×÷Õß·Ö¹¤ÔÚ×÷Õß¹±Ï×ÀïдÁË...

ÄÇÓ¦¸ÃûɶÁ˰É

·¢×ÔСľ³æAndroid¿Í»§¶Ë
it'smylife£¬nowornever
4Â¥2023-06-08 13:11:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nono2009

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

No gains, no pains.

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÖðÌõ¼ì²é£¬ÊÇ·ñÓÐÒÅ©֮´¦

·¢×ÔСľ³æAndroid¿Í»§¶Ë
5Â¥2023-06-09 00:06:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

felixnb

ľ³æ (ÕýʽдÊÖ)

½¨ÒéÈ¥¿´¼¸Æª¸ÃÔÓÖ¾×îеÄÎÄÕ£¬¿´¿´Â©ÁËÄÄÒ»²¿·Ö

·¢×ÔСľ³æIOS¿Í»§¶Ë
´óË®±È
6Â¥2023-06-09 00:47:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bobvan

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Conflicts of interest or competing interests: A statement that declares all relationships or interests of the manuscript¡¯s authors that could potentially influence or bias the submitted work. If no conflicts of interest exist, the authors must include a statement stating this. Details on potential conflicts of interest are included under Publishing Ethics. Manuscripts that do not include a conflict of interest statement will be returned to the authors for amendment before any editorial consideration.

Data and code availability: A brief description what data or code is available to readers and how it can be accessed, for example, a DOI to an electronic repository.


Ethical approval: A statement that approval was granted to carry out experiments involving human tissue by an institutional review board or equivalent ethics committee.
7Â¥2023-06-10 00:36:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nihaoash

гæ (ÕýʽдÊÖ)

ÉùÃ÷ÀïÃæÒ²ÒªËµÃ÷×÷Õߣ¬¹À¼ÆÄ㻹ÊÇÄÄÒ»Ìõ©ÁË

·¢×ÔСľ³æIOS¿Í»§¶Ë
9Â¥2023-06-15 06:56:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÅíÈñ1992

ľ³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸ù¾ÝÓʼþÄÚÈÝ£¬ÄãÐèÒªÂÛÎÄÖÐÌí¼ÓÒ»¸ö°üº¬ÖÂл¡¢×÷Õß¹±Ïס¢ÀûÒæ³åÍ»¡¢Êý¾Ý¿ÉÓÃÐÔ¡¢²¹³äÐÅÏ¢ºÍÂ×ÀíÉóÅúµÄÕ½ڡ£ÕâЩÐÅÏ¢¶ÔÓÚÈ·±£Ñ§ÊõÂÛÎĵijÏÐźÍ͸Ã÷¶È·Ç³£ÖØÒª¡£ÄãÐèÒªÔÚÎÄÖÐÌí¼ÓÕâЩÐÅÏ¢»òÕßÖØÕûÒ»ÏÂÂÛÎÄ¿ò¼ÜºÍ¸ñʽ£¬Ê¹µÃÕâЩÐÅÏ¢¿ÉÒԵõ½Ç¡µ±µÄչʾºÍÌåÏÖ¡£×îºóÈ·¶¨ÓʼþÄÚÈÝûÓÐÒÅ©¼´¿ÉÖØÐÂÌá½»¡£Èç¹û»¹ÓÐÎÊÌ⣬¿ÉÒÔ¼ÌÐøÓë±à¼­×鹵ͨ¹ý¡£
10Â¥2023-06-15 08:54:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ludedai µÄÖ÷Ìâ¸üÐÂ
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 319·Ö085702°²È«¹¤³ÌÇóµ÷¼Á +4 rious 2026-04-05 4/200 2026-04-06 11:08 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] ÇóÖú071001µ÷¼Á£¡£¡£¡ +4 »ÆÊØËÉ 2026-04-05 5/250 2026-04-06 10:55 by 1028907439
[¿¼ÑÐ] 0857´óÀà»·¾³¹¤³ÌBÇøÇóµ÷¼Á +3 ¹¨ÓíÃú 2026-04-05 3/150 2026-04-06 10:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬085600£¬344·ÖÇóµ÷¼Á +9 µ÷¼ÁÉϰ¶«^ 2026-04-05 10/500 2026-04-06 09:30 by dongzh2009
[¿¼ÑÐ] 308Çóµ÷¼Á +4 maverick^_^ 2026-04-03 4/200 2026-04-05 19:08 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 296Çóµ÷¼Á +3 Íô£¡£¿£¡ 2026-04-05 5/250 2026-04-05 17:38 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005 +6 ioodiiij 2026-04-04 6/300 2026-04-05 10:09 by guoweigw
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ0710£¨A£©³õÊÔ329·Ö Çóµ÷¼Á +4 Ò»Ãû26¿¼ÑÐÉú 2026-04-04 4/200 2026-04-05 10:01 by barlinike
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-03-31 4/200 2026-04-04 13:34 by 1753564080
[¿¼ÑÐ] ±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á +9 âÖÖ111 2026-04-04 9/450 2026-04-04 11:01 by tangruihua
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö +15 ˶ÐǸ° 2026-04-03 15/750 2026-04-04 01:01 by userper
[¿¼ÑÐ] 274Çóµ÷¼Á +9 ˳Àí³ÉÕÅ 2026-04-03 10/500 2026-04-03 15:10 by °¡¿¡£¡
[¿¼ÑÐ] Çóµ÷¼Á²»Ìôרҵ +3 xrh030412 2026-04-01 3/150 2026-04-03 14:40 by µªÆøÆøÆø
[˶²©¼ÒÔ°] ÇóÀÏʦÊÕÁô +9 lllq123 2026-04-03 9/450 2026-04-03 13:48 by ºôÎü¶¼ÊǼõ·Ê
[¿¼ÑÐ] 330Çóµ÷¼Á +3 °×ÉñÎØºôºô 2026-04-02 3/150 2026-04-03 10:15 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-04-02 6/300 2026-04-02 21:54 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼Á +7 Aniyaio 2026-04-02 7/350 2026-04-02 16:42 by zzsw+
[¿¼ÑÐ] 0710ÉúÎïѧ£¬325Çóµ÷¼Á +3 mkkkkkl 2026-04-01 3/150 2026-04-02 09:48 by Jaylen.
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ¼ÆËã»úר˶£¬³õÊÔ373£¬Áù¼¶Í¨¹ý£¬ +3 ¼ÆËã»ú×·ÃÎÈË 2026-04-01 3/150 2026-04-02 07:57 by fxue1114
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û